SYMBRAVO
Active substance: MELOXICAM, RIZATRIPTAN BENZOATE
TABLET · MELOXICAM 20 mg/1, RIZATRIPTAN BENZOATE 10 mg/1
United StatesActive
Marketing holder: Axsome Therapeutics, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- MELOXICAM · 20 mg/1
- RIZATRIPTAN BENZOATE · 10 mg/1
Products containing meloxicam in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 161 |
|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2d59-77ad-b88e-93dd7b5fc714,01a1208c-3110-7f35-bdbe-eae40bb97b2c,01a1208c-346b-75c0-8ae3-6e42134b72a8,01a1208c-3920-73ff-966a-0972a807dd50,01a1208c-419c-73d1-80c1-c2dafdb80001;count=152 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 81968-020
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 81968-020 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 81968-020 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 81968-020 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 81968-020 · Verified 2026-10-09 · open in source